| Toward nanotechnology-enabled approaches against the COVID-19 pandemic C Weiss, M Carriere, L Fusco, I Capua, JA Regla-Nava, M Pasquali, ... ACS nano 14 (6), 6383-6406, 2020 | 569 | 2020 |
| Safety assessment of graphene-based materials: focus on human health and the environment B Fadeel, C Bussy, S Merino, E Vázquez, E Flahaut, F Mouchet, ... ACS nano 12 (11), 10582-10620, 2018 | 510 | 2018 |
| Graphene as cancer theranostic tool: progress and future challenges M Orecchioni, R Cabizza, A Bianco, LG Delogu Theranostics 5 (7), 710, 2015 | 269 | 2015 |
| Functionalized multiwalled carbon nanotubes as ultrasound contrast agents LG Delogu, G Vidili, E Venturelli, C Ménard-Moyon, MA Zoroddu, G Pilo, ... Proceedings of the National Academy of Sciences 109 (41), 16612-16617, 2012 | 161 | 2012 |
| CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2 D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ... British journal of cancer 109 (9), 2412-2423, 2013 | 150 | 2013 |
| Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ... Oncoimmunology 6 (2), e1253654, 2017 | 149 | 2017 |
| Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells M Orecchioni, D Bedognetti, L Newman, C Fuoco, F Spada, W Hendrickx, ... Nature communications 8 (1), 1109, 2017 | 141 | 2017 |
| Impact of carbon nanotubes and graphene on immune cells M Orecchioni, D Bedognetti, F Sgarrella, FM Marincola, A Bianco, ... Journal of translational medicine 12, 1-11, 2014 | 137 | 2014 |
| Functionalized carbon nanotubes as immunomodulator systems M Pescatori, D Bedognetti, E Venturelli, C Ménard-Moyon, C Bernardini, ... Biomaterials 34 (18), 4395-4403, 2013 | 131 | 2013 |
| Photodynamic therapy based on graphene and MXene in cancer theranostics A Gazzi, L Fusco, A Khan, D Bedognetti, B Zavan, F Vitale, A Yilmazer, ... Frontiers in bioengineering and biotechnology 7, 295, 2019 | 128 | 2019 |
| Graphene and the immune system: challenges and potentiality M Orecchioni, C Ménard-Moyon, LG Delogu, A Bianco Advanced drug delivery reviews 105, 163-175, 2016 | 121 | 2016 |
| Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue E Fiorillo, V Orru, SM Stanford, Y Liu, M Salek, N Rapini, AD Schenone, ... Journal of biological chemistry 285 (34), 26506-26518, 2010 | 119 | 2010 |
| Infectious diseases and autoimmunity LG Delogu, S Deidda, G Delitala, R Manetti The Journal of Infection in Developing Countries 5 (10), 679-687, 2011 | 118 | 2011 |
| Molecular and genomic impact of large and small lateral dimension graphene oxide sheets on human immune cells from healthy donors M Orecchioni, DA Jasim, M Pescatori, R Manetti, C Fozza, F Sgarrella, ... Advanced healthcare materials 5 (2), 276-287, 2016 | 105 | 2016 |
| Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis TL Spivey, L Uccellini, ML Ascierto, G Zoppoli, V De Giorgi, LG Delogu, ... Journal of translational medicine 9, 1-22, 2011 | 102 | 2011 |
| Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics L Fusco, A Gazzi, G Peng, Y Shin, S Vranic, D Bedognetti, F Vitale, ... Theranostics 10 (12), 5435, 2020 | 101 | 2020 |
| Effects of air pollution particles (ultrafine and fine particulate matter) on mitochondrial function and oxidative stress–Implications for cardiovascular and neurodegenerative … A Daiber, M Kuntic, O Hahad, LG Delogu, S Rohrbach, F Di Lisa, ... Archives of biochemistry and biophysics 696, 108662, 2020 | 92 | 2020 |
| Ex Vivo Impact of Functionalized Carbon Nanotubes on Human Immune Cells LG Delogu, E Venturelli, R Manetti, GA Pinna, C Carru, R Madeddu, ... Nanomedicine 7 (2), 231-243, 2012 | 89 | 2012 |
| 2D MXenes with antiviral and immunomodulatory properties: a pilot study against SARS-CoV-2 MA Unal, F Bayrakdar, L Fusco, O Besbinar, CE Shuck, S Yalcin, ... Nano Today 38, 101136, 2021 | 87 | 2021 |
| Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? G Mameli, G Madeddu, A Mei, E Uleri, L Poddighe, LG Delogu, I Maida, ... PLoS One 8 (11), e78474, 2013 | 87 | 2013 |
